张文骥,张婷,许英健,贾儒林
ZHANG Wen-ji,ZHANG Ting,XU Ying-jian,JIA Ru-lin

• 1:中国刑事警察学院法医学系
• 2:中国刑事警察学院法化学系

摘要(Abstract)：

目的建立高效液相色谱-串联质谱法(HPLC-MS/MS)测定汗液中美托洛尔(metoprolol,MET)及其代谢产物α-羟化美托洛尔(α-hydro-metoprolol,α-MET)的质量浓度。方法采用Finnigan液相色谱仪串联LXQ离子阱质谱仪检测,流动相为乙腈-甲醇-体积分数0.1%甲酸水溶液(体积比20∶20∶60),采用SRM模式,正离子模式监测。采用内标法计算待测样品的质量浓度,内标物为盐酸普萘洛尔(proprandoIhydroc.hloride,PRO)。结果MET在载药量0.5~50ng内、α-MET在载药量2.5~50ng内线性关系良好;MET(α-MET)低、中、高三个质量浓度的回收率分别为89.9%(89.5%)、103.5%(83.6%)和92.5%(87.3%);汗液中MET检出时间为服药后1~18h,α-MET检出时间为服药后2~16h。结论本方法适用于同时测定汗液中美托洛尔及其代谢产物的含量,可为药物的体外监测提供参考。
Objective To establish a HPLC-MS/MS method for the determination of metoprolol and its metaboliteα-hydro-metoprolol secreted in human sweat.Methods The sweat sample was processed and chromatographed with the mobile phase consisting of acetonitrile-methanol-0.1%formic acid aqueous solution(20∶20∶60,V/V/V).SRM mode was applied and operated in the positive ion mode.The drug concertation was calculated using internal standard method with propranolol hydrochloride as the internal standard substance.Results The standard curve of MET was linear over the drug loading range from0.5-50 ng.The standard curve ofα-MET was linear over the drug loading range from2.5-50 ng.The recovery of MET(andα-MET)at low,medium and high concentrations were89.9%(89.5%),103.5%(83.6%)and 92.5%(87.3%),respectively.The MET in sweat could be detected from1 h after administration through to 18 h,and theα-MET from2 h through to 16 h.Conclusions This method applies for determining the concentration of metoprolol and its metaboliteα-hydro-metoprolol secreted in human sweat,and is suitable for clinical monitor.

关键词(KeyWords)： 汗液;美托洛尔;α-羟化美托洛尔;液质联用
sweat;metoprolol;α-hydroxyl-metoprolol;HPLC-MS/MS

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 张文骥,张婷,许英健,贾儒林
ZHANG Wen-ji,ZHANG Ting,XU Ying-jian,JIA Ru-lin

DOI: 10.14066/j.cnki.cn21-1349/r.2017.06.007

参考文献(References)：

• [1]代铁成,赵月.美托洛尔对高血压患者运动后血压的影响[J].心血管康复医学杂志,2011,20(1):25-27.
• [2]BENFIELD P,STEPHEN P,CLISSOLD-REX N.Metoprolol,an updated review of its pharmacodynamic and pharmacokinetic properties,and therapeutic efficacy,in hypertension,ischaemic heart disease and related cardiovascular disorders[J].Drug Evaluation,1986,31(1):376-429.
• [3]AQIL M,ALI A,AHAD A,et al.A validated HPLC method for estimation of metoprolol in human plasma[J].Acta Chromatographica,2007,19:130-140.
• [4]ZHANG Y,WU H L,XIA A L,et al.Fluorescence determination of metoprolol in human plasma by trilinear decomposition-based calibration techniques[J],Analytical and Bioanalytical Chemistry,2006,386:1741-1748,
• [5]YILMAZ B,ARSLAN S,AKBA V.Gas chromatography-mass spectrometry method for determination of metoprolol in the patients with hypertension[J],Talanta,2009,80(1):346-351.
• [6]高峰.复方美托洛尔人体药代动力学研究[D].长春:吉林大学,2010.
• [7]姚亚敏,沐俊,孙骥,等.洛匹那韦药代动力学的研究进展[J].药学实践杂志,2012,30(5):336-339.
• [8]董淑英,童旭辉,李见春,等.液相色谱-串联质谱法测定美托洛尔缓释片人体药动学及生物等效性[J].中国新药与临床杂志,2008,27(6):429-433.